#FamilyHeartSummit24 Not able to make it to Dallas for the Family Heart Foundation Global Summit? ✅ out HCPLive for live meeting coverage! hcplive.com/conference/fam… Katherine Wilemon Josh Knowles Christie Ballantyne Fatima Rodriguez Suzanne Woodward Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 ASPC National Lipid Association Association of Black Cardiologists

10 years of #Familyheart24 - so much accomplished - Creates (2) ICD-10 codes / 6k enrolled registry / 230 ambassadors / 650 HCPs on Family Heart Foundation map / consensus statement - and so much more.

Helen Hobbs receives the #familyheartsummit24 Pioneer Award - the honor is ours.

#FamilyHeartSummit24 Hobbs & Cohen Lab Dr. Helen Hobbs presenting her early work on FH which led her to our French Canadians leading to greater understanding of the genetic mutation that is so common in my country in Quebec 🇨🇦 Further work spread to more diverse popln #FHSummit24

The patients’ voice always matters. #KnowFH #FHSummit24 Elevated LDL in a child is NOT because of too many cupcakes Family Heart Foundation #FH means checking the whole family #cascadescreening

Keith C. Ferdinand, MD, FACC, FAHA, FNLA presenting the @FamilHeartFdn database which shows: 📍 despite dx of #FH: 30% on noTx 📍 61% w/ LDL>70 📍Only 13/100 adequately Tx 📍disparities in management of FH persist: worse control in women, young & Black 📍adherence reflects SDOH & access 🚨WE MUST DO BETTER!

Heather M. Johnson, MD, MMM, FAHA, FACC, FASPC presenting on misinformation that affects our #FH patients #FHSummit24 🫀 Misinformation comes from many sources 🫀most especially true for treating LDL/ Cholesterol: we have the evidence and yet the myths appear in our clinics everyday 🫀it is not just BOTs

Social media can both help and harm our patients. We need to be there to combat misinformation #FamilyHeartSummit24 #FHSummit24 #KnowFH

THE Clyde Yancy, MD, MSc discuss if we are making progress in ⤵️ disparities in Healthcare 40 years post Heckler Report: NO WE HAVE NOT! 🫀Ms Heckler-secretary HHS called disparities an affront to 🇺🇸 ideals 🫀Need to ⤵️ bias: Bias is REAL 🫀diversity=Inclusive Excellence #FHSummit24

Christie Ballantyne discusses advances on nonstatin Tx at #FHSummit24 ♥️Look at how many LDL⤵️ Tx we have! How far we have come! ♥️ Guidelines & Quality measures necessary to help get patients LDL controlled: optimal LDL goals will help us “get to goal” ♥️ Lp(a) new target now

Amit Khera #FHSummit24 #FINDFH #KnowFH 🧪 FIND FH machine-learning algorithm: validated w/ 87% accuracy in national database 🧪incomplete data affects accuracy 🧪accuracy does not =actionable: we can still reach out to patients identified 🧪Identification is just 1st step

Fatima Rodriguez #FHSummit24 discusses AI to improve Health Equity 🫀CAC useful but access often limited by 💰 🫀AI to identify Calcification on any chest CT makes it more accessible & more equitable 🫀over half started statin when notified

Dr. Steve Nissen #FHSummit24 #CvPrev #CardioTwitter 🚨🚨🚨We are failing patients🚨🚨🚨 🚨🚨🚨After 3 decades our practice pattern is the same It started in the 1970’s with the Cholesterol Skeptics…& now just stronger despite all the evidence #CVPrev #CardioTwitter

#FamilyHeartSummit24 Wonderful keynote by Dr Steve Nissen from Cleveland Clinic at the Family Heart Foundation Summit! Really superb review of lessons learned!! “Our guidelines are 10-15 behind the science”. Amen! Josh Knowles Seth J. Baum MD Keith C. Ferdinand, MD, FACC, FAHA, FNLA

#FamilyHeartSummit2024 Harpreet Bhatia discussing why Lp(a) is actionable today! Valuable way to refine risk and intensify prevention strategies. Genetics is not destiny.

Michelle O'Donoghue had led key trials on Lp(a) #FHSummit24 📍may require significant ⤵️ in Lp(a) to get benefit but trials are ongoing 📍siRNA class: longer duration & had ⤵️⤵️ >80% of Lp(a)- dose dependent. (95%⤵️ with olpasiran!) 📍1 year off Tx: 40-50%⤵️ Lp(a) with Olp.

#FamilyHeartSummit24 Such a great presentation by Michelle O'Donoghue on therapies in development for Lp(a)! Exciting to see the programs from Novartis Amgen 🧪🔬🧬 Eli Lilly and Company & Silence Therapeutics.🙏🏻 #KnowLpa Family Heart Foundation Mass General Brigham Josh Knowles J. Antonio G. Lopez, MD, FACC, FAHA, FNLA, FASPC Seth J. Baum MD

Family Heart Foundation Seth J. Baum MD John M. Clymer J. Antonio G. Lopez, MD, FACC, FAHA, FNLA, FASPC Josh Knowles Association of Black Cardiologists National Forum National Medical Association National Hispanic Medical Association BLKHLTH Black Health Matters

Elevated remnant cholesterol remains a likely cause of ASCVD in diabetes. Remnant cholesterol-lowering therapies should also lower apoB levels to reduce risk of ASCVD: rdcu.be/dVQJg Risk of ASCVD in diabetes in the Copenhagen General Population Study:

A tremendous honor to be named the Gerald M. Reaven, MD Professor of Endocrinology Stanford Medicine. The 'Father of Insulin Resistance,' Dr. Reaven was a true legend in Endocrinology. I'll always remember how he welcomed me to Stanford Endocrinology with stories of science and the Division.